A method for detecting fatty liver disease or predicting risk, a diagnostic kit and biomarker for detecting fatty liver disease, a method for determining the degree of liver fibrosis in a subject, and the degree of liver fibrosis in a subject Biomarker for judgment

摘要

It is an object of the present invention to provide a new method for diagnosing fatty liver disease that can be carried out more simply and does not place a burden on patients and medical staff. Any of long-chain acylcarnitines selected from the group consisting of octadecenoylcarnitine, tetradecenoylcarnitine, tetradecanoylcarnitine, hexadecanoylcarnitine, octadecanoylcarnitine, and octadecaenoylcarnitine in a body fluid sample The above-mentioned problem can be solved by measuring one or more quantities and comparing them with a reference value.